TARS logo

Tarsus Pharmaceuticals (TARS) Operating expenses

annual operating expenses:

$290.70M+$131.68M(+82.81%)
December 31, 2024

Summary

  • As of today (May 24, 2025), TARS annual total operating expenses is $290.70 million, with the most recent change of +$131.68 million (+82.81%) on December 31, 2024.
  • During the last 3 years, TARS annual operating expenses has risen by +$223.59 million (+333.17%).
  • TARS annual operating expenses is now at all-time high.

Performance

TARS Operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARSincome statement metrics

quarterly operating expenses:

$99.40M+$13.50M(+15.72%)
March 31, 2025

Summary

  • As of today (May 24, 2025), TARS quarterly total operating expenses is $99.40 million, with the most recent change of +$13.50 million (+15.72%) on March 31, 2025.
  • Over the past year, TARS quarterly operating expenses has increased by +$35.76 million (+56.19%).
  • TARS quarterly operating expenses is now at all-time high.

Performance

TARS quarterly operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTARSincome statement metrics

Operating expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

TARS Operating expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+82.8%+56.2%
3 y3 years+333.2%+396.4%
5 y5 years+6663.5%+4593.3%

TARS Operating expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+333.2%at high+397.5%
5 y5-yearat high+6663.5%at high+4593.3%
alltimeall timeat high>+9999.0%at high>+9999.0%

TARS Operating expenses History

DateAnnualQuarterly
Mar 2025
-
$99.40M(+15.7%)
Dec 2024
$290.70M(+82.8%)
$85.90M(+22.7%)
Sep 2024
-
$70.04M(-1.5%)
Jun 2024
-
$71.11M(+11.7%)
Mar 2024
-
$63.64M(+13.0%)
Dec 2023
$159.01M(+81.6%)
$56.31M(+32.7%)
Sep 2023
-
$42.43M(+29.3%)
Jun 2023
-
$32.82M(+19.6%)
Mar 2023
-
$27.45M(+11.3%)
Dec 2022
$87.57M
$24.66M(+7.7%)
Sep 2022
-
$22.91M(+14.7%)
Jun 2022
-
$19.98M(-0.2%)
DateAnnualQuarterly
Mar 2022
-
$20.03M(+35.2%)
Dec 2021
$67.11M(+148.6%)
$14.81M(-12.3%)
Sep 2021
-
$16.88M(+20.6%)
Jun 2021
-
$14.00M(-34.7%)
Mar 2021
-
$21.42M(+86.6%)
Dec 2020
$27.00M(+528.2%)
$11.48M(+13.2%)
Sep 2020
-
$10.14M(+210.8%)
Jun 2020
-
$3.26M(+54.1%)
Mar 2020
-
$2.12M(+95.4%)
Dec 2019
$4.30M(+218.4%)
$1.08M(+71.2%)
Sep 2019
-
$633.00K
Dec 2018
$1.35M
-

FAQ

  • What is Tarsus Pharmaceuticals annual total operating expenses?
  • What is the all time high annual operating expenses for Tarsus Pharmaceuticals?
  • What is Tarsus Pharmaceuticals annual operating expenses year-on-year change?
  • What is Tarsus Pharmaceuticals quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Tarsus Pharmaceuticals?
  • What is Tarsus Pharmaceuticals quarterly operating expenses year-on-year change?

What is Tarsus Pharmaceuticals annual total operating expenses?

The current annual operating expenses of TARS is $290.70M

What is the all time high annual operating expenses for Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals all-time high annual total operating expenses is $290.70M

What is Tarsus Pharmaceuticals annual operating expenses year-on-year change?

Over the past year, TARS annual total operating expenses has changed by +$131.68M (+82.81%)

What is Tarsus Pharmaceuticals quarterly total operating expenses?

The current quarterly operating expenses of TARS is $99.40M

What is the all time high quarterly operating expenses for Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals all-time high quarterly total operating expenses is $99.40M

What is Tarsus Pharmaceuticals quarterly operating expenses year-on-year change?

Over the past year, TARS quarterly total operating expenses has changed by +$35.76M (+56.19%)
On this page